Enfusion's chief people officer sells $8,195 in stock

Bastone Bronwen, Chief People Officer of Enfusion, Inc. (NYSE:ENFN), recently sold a portion of the company's Class A common stock. According to a filing with the Securities and Exchange Commission, Bronwen sold 809 shares on January 7, 2025, at a weighted average price of $10.13 per share, totaling approximately $8,195. The software company, currently valued at $1.3 billion, maintains a "GOOD" financial health score according to InvestingPro analysis.

The transaction was carried out to cover tax withholding obligations related to the issuance of shares and was not a discretionary trade by Bronwen. Following this sale, Bronwen holds 194,885 shares directly in Enfusion. The shares were sold in multiple transactions at prices ranging from $10.05 to $10.36. With net income expected to grow this year and current trading near its Fair Value, InvestingPro subscribers can access 10+ additional exclusive insights and detailed insider trading patterns for informed investment decisions.

In other recent news, Enfusion Inc. has reported a prosperous third quarter in 2024, with a 15% increase in year-over-year revenue, reaching $51.2 million. The company's adjusted EBITDA was $11.1 million, marking a 21.8% margin. A key point of this growth was the acquisition of 38 new clients, increasing the total to 894. This growth was seen across all regions, with the Americas experiencing a 17% increase, EMEA a 22% increase, and Asia-Pacific a 6% increase.

Enfusion's annual recurring revenue (ARR) surpassed $200 million, a 14% year-over-year increase, while the net dollar retention (NDR) rate remained steady at 102%. The company has tightened its full-year revenue guidance to between $202 million and $205 million, with EBITDA guidance between $41 million and $45 million.

Despite some moderation in back book growth and a slight deceleration in ARR growth, Enfusion's management remains confident in achieving its medium-term revenue growth target of 20% to 22% from 2025 to 2027. The company's strategic focus on product innovation and market expansion has led to a significant increase in new client acquisitions and enhancement of its product suite. These are recent developments that indicate a positive future trajectory for the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.